Relevance and acceptability of using the Quantiferon gold test (QGIT) to screen CD4 blood draws for latent TB infection among PLHIV in South Africa: formative qualitative research findings from the TEKO trial

BACKGROUND: Tuberculosis (TB) is the leading cause of mortality among people living with HIV (PLHIV), despite the availability of effective preventive therapy. The TEKO trial is assessing the impact of using a blood test, Quantiferon-TB Gold In-Tube Test (QGIT), to screen for latent TB compared to t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kerrigan, Deanna, Tudor, Carrie, Motlhaoleng, Katlego, Lebina, Limakatso, Qomfu, Cokiswa, Variava, Ebrahim, Chon, Sandy, Martinson, Neil, Golub, Jonathan E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902890/
https://www.ncbi.nlm.nih.gov/pubmed/29661197
http://dx.doi.org/10.1186/s12913-018-3088-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902890/
https://www.ncbi.nlm.nih.gov/pubmed/29661197
http://dx.doi.org/10.1186/s12913-018-3088-8

Ejemplares similares